GRRM.F Stock Overview
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 2/6 |
| Dividends | 3/6 |
Gerresheimer AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €105.35 |
| 52 Week High | €130.00 |
| 52 Week Low | €91.00 |
| Beta | 0.90 |
| 1 Month Change | -3.93% |
| 3 Month Change | n/a |
| 1 Year Change | 9.40% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 387.73% |
Recent News & Updates
Recent updates
Shareholder Returns
| GRRM.F | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | -3.6% | -4.1% | -3.2% |
| 1Y | 9.4% | -6.7% | 19.3% |
Return vs Industry: GRRM.F exceeded the US Life Sciences industry which returned -6.7% over the past year.
Return vs Market: GRRM.F underperformed the US Market which returned 19.3% over the past year.
Price Volatility
| GRRM.F volatility | |
|---|---|
| GRRM.F Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 7.0% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: GRRM.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine GRRM.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1864 | 11,947 | Dietmar Siemssen | www.gerresheimer.com |
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.
Gerresheimer AG Fundamentals Summary
| GRRM.F fundamental statistics | |
|---|---|
| Market cap | US$3.64b |
| Earnings (TTM) | US$124.73m |
| Revenue (TTM) | US$2.13b |
29.2x
P/E Ratio1.7x
P/S RatioIs GRRM.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GRRM.F income statement (TTM) | |
|---|---|
| Revenue | €2.00b |
| Cost of Revenue | €1.41b |
| Gross Profit | €592.85m |
| Other Expenses | €475.77m |
| Earnings | €117.09m |
Last Reported Earnings
Feb 29, 2024
Next Earnings Date
Jul 11, 2024
| Earnings per share (EPS) | 3.39 |
| Gross Margin | 29.66% |
| Net Profit Margin | 5.86% |
| Debt/Equity Ratio | 76.4% |
How did GRRM.F perform over the long term?
See historical performance and comparison